Viewing Study NCT02812693


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-02-26 @ 7:25 PM
Study NCT ID: NCT02812693
Status: WITHDRAWN
Last Update Posted: 2018-04-05
First Post: 2016-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification
Sponsor: Joanne Jeter
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module